266 related articles for article (PubMed ID: 9205080)
21. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
[TBL] [Abstract][Full Text] [Related]
22. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
Brenner AJ; Aldaz CM
Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
[TBL] [Abstract][Full Text] [Related]
25. Codeletion of p15 and p16 in primary malignant mesothelioma.
Xio S; Li D; Vijg J; Sugarbaker DJ; Corson JM; Fletcher JA
Oncogene; 1995 Aug; 11(3):511-5. PubMed ID: 7630635
[TBL] [Abstract][Full Text] [Related]
26. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Fong KM; Sekido Y; Minna JD; Hong WK; Mao L
Cancer Res; 1997 Feb; 57(3):400-3. PubMed ID: 9012464
[TBL] [Abstract][Full Text] [Related]
27. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
Liu Q; Neuhausen S; McClure M; Frye C; Weaver-Feldhaus J; Gruis NA; Eddington K; Allalunis-Turner MJ; Skolnick MH; Fujimura FK
Oncogene; 1995 Mar; 10(6):1061-7. PubMed ID: 7700630
[TBL] [Abstract][Full Text] [Related]
28. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
Knapek DF; Serrano M; Beach D; Trono D; Walker CL
Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
30. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
[TBL] [Abstract][Full Text] [Related]
32. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
[TBL] [Abstract][Full Text] [Related]
33. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
34. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
[TBL] [Abstract][Full Text] [Related]
35. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.
Rodabaugh KJ; Biggs RB; Qureshi JA; Barrett AJ; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1995 Oct; 11(7):1249-54. PubMed ID: 7478544
[TBL] [Abstract][Full Text] [Related]
36. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia.
Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP
Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts.
Obata M; Lee GH; Kanda H; Kitagawa T; Ogawa K
Mol Carcinog; 1997 May; 19(1):17-24. PubMed ID: 9180924
[TBL] [Abstract][Full Text] [Related]
38. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
Cairns P; Tokino K; Eby Y; Sidransky D
Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
[TBL] [Abstract][Full Text] [Related]
39. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors.
Herzog CR; Wiseman RW; You M
Cancer Res; 1994 Aug; 54(15):4007-10. PubMed ID: 8033131
[TBL] [Abstract][Full Text] [Related]
40. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]